Literature DB >> 19515692

Identification of Dlk1, Ptpru and Klhl1 as novel Nurr1 target genes in meso-diencephalic dopamine neurons.

Frank M J Jacobs1, Annemarie J A van der Linden, Yuhui Wang, Lars von Oerthel, Hei Sook Sul, J Peter H Burbach, Marten P Smidt.   

Abstract

The orphan nuclear receptor Nurr1 is essential for the development of meso-diencephalic dopamine (mdDA) neurons and is required, together with the homeobox transcription factor Pitx3, for the expression of genes involved in dopamine metabolism. In order to elucidate the molecular mechanisms that underlie the neuronal deficits in Nurr1(-/-) mice, we performed combined gene expression microarrays and ChIP-on-chip analysis and thereby identified Dlk1, Ptpru and Klhl1 as novel Nurr1 target genes in vivo. In line with the previously described cooperativity between Nurr1 and Pitx3, we show that the expression of Ptpru and Klhl1 in mdDA neurons is also dependent on Pitx3. Furthermore, we demonstrate that Nurr1 interacts with the Ptpru promoter directly and requires Pitx3 for full expression of Ptpru in mdDA neurons. By contrast, the expression of Dlk1 is maintained in Pitx3(-/-) embryos and is even expanded into the rostral part of the mdDA area, suggesting a unique position of Dlk1 in the Nurr1 and Pitx3 transcriptional cascades. Expression analysis in Dlk1(-/-) embryos reveals that Dlk1 is required to prevent premature expression of Dat in mdDA neuronal precursors as part of the multifaceted process of mdDA neuronal differentiation driven by Nurr1 and Pitx3. Taken together, the involvement of Nurr1 and Pitx3 in the expression of novel target genes involved in important neuronal processes such as neuronal patterning, axon outgrowth and terminal differentiation, opens up new avenues to study the properties of mdDA neurons during development and in neuronal pathology as observed in Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19515692      PMCID: PMC3266485          DOI: 10.1242/dev.037556

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  51 in total

Review 1.  Receptor and nonreceptor protein tyrosine phosphatases in the nervous system.

Authors:  S Paul; P J Lombroso
Journal:  Cell Mol Life Sci       Date:  2003-11       Impact factor: 9.261

Review 2.  Strategies to unravel molecular codes essential for the development of meso-diencephalic dopaminergic neurons.

Authors:  F M J Jacobs; S M Smits; K J M Hornman; J P H Burbach; M P Smidt
Journal:  J Physiol       Date:  2006-06-29       Impact factor: 5.182

3.  The role of Ret receptor tyrosine kinase in dopaminergic neuron development.

Authors:  L Li; Y Su; C Zhao; H Zhao; G Liu; J Wang; Q Xu
Journal:  Neuroscience       Date:  2006-07-31       Impact factor: 3.590

4.  Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors.

Authors:  J H Baik; R Picetti; A Saiardi; G Thiriet; A Dierich; A Depaulis; M Le Meur; E Borrelli
Journal:  Nature       Date:  1995-10-05       Impact factor: 49.962

5.  Protein-tyrosine phosphatase PCP-2 inhibits beta-catenin signaling and increases E-cadherin-dependent cell adhesion.

Authors:  He-Xin Yan; Wen Yang; Rui Zhang; Lei Chen; Liang Tang; Bo Zhai; Shu-Qin Liu; Hui-Fang Cao; Xiao-Bo Man; Hong-Ping Wu; Meng-Chao Wu; Hong-Yang Wang
Journal:  J Biol Chem       Date:  2006-03-30       Impact factor: 5.157

6.  Receptor tyrosine phosphatases guide vertebrate motor axons during development.

Authors:  Laurie Stepanek; Andrew W Stoker; Esther Stoeckli; John L Bixby
Journal:  J Neurosci       Date:  2005-04-13       Impact factor: 6.167

7.  Midbrain dopaminergic neurons: determination of their developmental fate by transcription factors.

Authors:  Horst H Simon; Lavinia Bhatt; Daniel Gherbassi; Paola Sgadó; Lavinia Alberí
Journal:  Ann N Y Acad Sci       Date:  2003-06       Impact factor: 5.691

8.  SCA8 repeat expansion: large CTA/CTG repeat alleles are more common in ataxic patients, including those with SCA6.

Authors:  Yuishin Izumi; Hirofumi Maruyama; Masaya Oda; Hiroyuki Morino; Takayuki Okada; Hidefumi Ito; Iwao Sasaki; Hiroyasu Tanaka; Osamu Komure; Fukashi Udaka; Shigenobu Nakamura; Hideshi Kawakami
Journal:  Am J Hum Genet       Date:  2003-01-21       Impact factor: 11.025

9.  Runx2 deficiency in chondrocytes causes adipogenic changes in vitro.

Authors:  Hirayuki Enomoto; Tatsuya Furuichi; Akira Zanma; Kei Yamana; Carolina Yoshida; Satoru Sumitani; Hiroyasu Yamamoto; Motomi Enomoto-Iwamoto; Masahiro Iwamoto; Toshihisa Komori
Journal:  J Cell Sci       Date:  2004-01-26       Impact factor: 5.285

10.  Involvement of Nurr1 in specifying the neurotransmitter identity of ventral midbrain dopaminergic neurons.

Authors:  Simone M Smits; Tiia Ponnio; Orla M Conneely; J Peter H Burbach; Marten P Smidt
Journal:  Eur J Neurosci       Date:  2003-10       Impact factor: 3.386

View more
  47 in total

1.  A functional NR4A nuclear receptor DNA-binding domain is required for organ development in Caenorhabditis elegans.

Authors:  Melissa Heard; Claude V Maina; Benjamin E Morehead; Marius C Hoener; Tri Q Nguyen; Christopher C Williams; Brian G Rowan; Chris R Gissendanner
Journal:  Genesis       Date:  2010-08       Impact factor: 2.487

Review 2.  NURR1 in Parkinson disease--from pathogenesis to therapeutic potential.

Authors:  Mickael Decressac; Nikolaos Volakakis; Anders Björklund; Thomas Perlmann
Journal:  Nat Rev Neurol       Date:  2013-10-15       Impact factor: 42.937

Review 3.  The role of NR4A transcription factors in memory formation.

Authors:  Josh D Hawk; Ted Abel
Journal:  Brain Res Bull       Date:  2011-02-18       Impact factor: 4.077

4.  MiR-126 Regulates Growth Factor Activities and Vulnerability to Toxic Insult in Neurons.

Authors:  Woori Kim; Haneul Noh; Yenarae Lee; Jeha Jeon; Arthi Shanmugavadivu; Donna L McPhie; Kwang-Soo Kim; Bruce M Cohen; Hyemyung Seo; Kai C Sonntag
Journal:  Mol Neurobiol       Date:  2014-11-19       Impact factor: 5.590

Review 5.  Molecular mechanisms of dopaminergic subset specification: fundamental aspects and clinical perspectives.

Authors:  Jesse V Veenvliet; Marten P Smidt
Journal:  Cell Mol Life Sci       Date:  2014-07-27       Impact factor: 9.261

Review 6.  Nurr1-Based Therapies for Parkinson's Disease.

Authors:  Jie Dong; Song Li; Jing-Lin Mo; Huai-Bin Cai; Wei-Dong Le
Journal:  CNS Neurosci Ther       Date:  2016-03-25       Impact factor: 5.243

Review 7.  Role of genomic imprinting in mammalian development.

Authors:  Thushara Thamban; Viplove Agarwaal; Sanjeev Khosla
Journal:  J Biosci       Date:  2020       Impact factor: 1.826

8.  DLK1 promotes neurogenesis of human and mouse pluripotent stem cell-derived neural progenitors via modulating Notch and BMP signalling.

Authors:  Beata Surmacz; Parinya Noisa; Jessica R Risner-Janiczek; Kailyn Hui; Mark Ungless; Wei Cui; Meng Li
Journal:  Stem Cell Rev Rep       Date:  2012-06       Impact factor: 5.739

9.  NR4A2: effects of an "orphan" receptor on sustained attention in a schizophrenic population.

Authors:  Inés Ancín; José A Cabranes; Blanca Vázquez-Álvarez; José Luis Santos; Eva Sánchez-Morla; Maaike Alaerts; Jurgen Del-Favero; Ana Barabash
Journal:  Schizophr Bull       Date:  2012-01-31       Impact factor: 9.306

10.  Vitamin C facilitates dopamine neuron differentiation in fetal midbrain through TET1- and JMJD3-dependent epigenetic control manner.

Authors:  Xi-Biao He; Mirang Kim; Seon-Young Kim; Sang-Hoon Yi; Yong-Hee Rhee; Taeho Kim; Eun-Hye Lee; Chang-Hwan Park; Shilpy Dixit; Fiona E Harrison; Sang-Hun Lee
Journal:  Stem Cells       Date:  2015-04       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.